Amarin Q2 2020 Results Conference Call Submitted by amarin on Tue, 07/21/2020 - 20:29 Home Event Amarin Q2 2020 Results Conference Call Read more about Amarin Q2 2020 Results Conference Call
Investor Call Discussing ACC Science Submitted by amarin on Sun, 03/29/2020 - 23:19 Home Event Investor Call Discussing ACC Science Read more about Investor Call Discussing ACC Science
Cowen and Company's 40th Annual Health Care Conference Submitted by amarin on Thu, 02/20/2020 - 12:18 Home Event Cowen and Company's 40th Annual Health Care Conference Read more about Cowen and Company's 40th Annual Health Care Conference
9th Annual SVB Leerink Global Healthcare Conference Submitted by amarin on Thu, 02/20/2020 - 12:09 Home Event 9th Annual SVB Leerink Global Healthcare Conference Read more about 9th Annual SVB Leerink Global Healthcare Conference
Amarin Q4 Results Conference Call Submitted by amarin on Wed, 02/19/2020 - 21:20 Home Event Amarin Q4 Results Conference Call Read more about Amarin Q4 Results Conference Call
38TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Submitted by amarin on Mon, 01/06/2020 - 13:48 Home Event 38TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Read more about 38TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk Submitted by amarin on Fri, 12/13/2019 - 22:35 Home Event Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovasc… Read more about Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk
Jefferies 2019 London Healthcare Conference Submitted by amarin on Mon, 11/11/2019 - 14:11 Home Event Jefferies 2019 London Healthcare Conference Read more about Jefferies 2019 London Healthcare Conference
AHA Investor Webcast Submitted by amarin on Tue, 11/05/2019 - 00:21 Home Event AHA Investor Webcast Read more about AHA Investor Webcast
Amarin Q3 Results Conference Call Submitted by amarin on Thu, 10/24/2019 - 20:39 Home Event Amarin Q3 Results Conference Call Read more about Amarin Q3 Results Conference Call
